Scott Dreyer, EVP & Chief Commercial Officer at COLLEGIUM PHARMACEUTICAL, INC (COLL), sold 47,120 shares at $32.28 ($1.5M) on 2024-01-16, disclosed to the SEC on 2024-01-18.
Scheduled sale ($1.5M) by EVP & Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.28 | 23,560 | $761K | 50.0% |
| 2 | $32.28 | 23,560 | $761K | 50.0% |
| Total | $32.28 avg | 47,120 | $1.5M | 100% |
| Filing → |
| COLL | SELL | 2025-08-20 | $1.3M | — | Filing → |
| COLL | SELL | 2025-08-15 | $370K | — | Filing → |
| COLL | SELL | 2025-03-24 | $1.2M | — | Filing → |